LA JOLLA PHARMACEUTICAL CO Insider Trading for December 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LA JOLLA PHARMACEUTICAL CO.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in LA JOLLA PHARMACEUTICAL CO for December 2018.
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 12.80 | 17 | 218 | 17 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 10.88 | 17 | 185 | 2,164 | 2.1 K to 2.2 K (+0.79 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 12.80 | 17 | 218 | 17 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 10.88 | 17 | 185 | 2,164 | 2.1 K to 2.2 K (+0.79 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 12.80 | 28 | 358 | 28 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 12.80 | 28 | 358 | 28 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 10.88 | 28 | 305 | 622 | 594 to 622 (+4.71 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 10.88 | 28 | 305 | 622 | 594 to 622 (+4.71 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 12.80 | 112 | 1,434 | 112 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 12.80 | 112 | 1,434 | 112 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 10.88 | 112 | 1,219 | 1,281,172 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 10.88 | 112 | 1,219 | 1,281,172 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 12.80 | 70 | 896 | 70 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 12.80 | 70 | 896 | 70 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 10.88 | 70 | 762 | 74,633 | 74.6 K to 74.6 K (+0.09 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 10.88 | 70 | 762 | 74,633 | 74.6 K to 74.6 K (+0.09 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 12.80 | 108 | 1,382 | 108 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 12.80 | 108 | 1,382 | 108 | |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 10.88 | 108 | 1,175 | 6,968 | 6.9 K to 7 K (+1.57 %) |
| Dec 17 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 10.88 | 108 | 1,175 | 6,968 | 6.9 K to 7 K (+1.57 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.47 | 26 | 376 | 26 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Option Exercise | A | 14.47 | 26 | 376 | 26 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.30 | 26 | 320 | 594 | 568 to 594 (+4.58 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | MULROY DENNIS | Chief Financial Off ... | Grant | A | 12.30 | 26 | 320 | 594 | 568 to 594 (+4.58 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.47 | 63 | 912 | 63 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Option Exercise | A | 14.47 | 63 | 912 | 63 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.30 | 63 | 775 | 74,563 | 74.5 K to 74.6 K (+0.08 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Rolke James | Chief Scientific Of ... | Grant | A | 12.30 | 63 | 775 | 74,563 | 74.5 K to 74.6 K (+0.08 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 14.47 | 100 | 1,447 | 100 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Option Exercise | A | 14.47 | 100 | 1,447 | 100 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 12.30 | 100 | 1,230 | 1,281,060 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | TIDMARSH GEORGE F | President, CEO & Se ... | Grant | A | 12.30 | 100 | 1,230 | 1,281,060 | 1.3 M to 1.3 M (+0.01 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 14.47 | 16 | 232 | 16 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Option Exercise | A | 14.47 | 16 | 232 | 16 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 12.30 | 16 | 197 | 2,147 | 2.1 K to 2.1 K (+0.75 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | Chawla Lakhmir S | Chief Medical Offic ... | Grant | A | 12.30 | 16 | 197 | 2,147 | 2.1 K to 2.1 K (+0.75 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 14.47 | 96 | 1,389 | 96 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Option Exercise | A | 14.47 | 96 | 1,389 | 96 | |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 12.30 | 96 | 1,181 | 6,860 | 6.8 K to 6.9 K (+1.42 %) |
| Dec 03 2018 | LJPC | LA JOLLA PHARMACEU ... | CARVER JENNIFER | Chief Operating Off ... | Grant | A | 12.30 | 96 | 1,181 | 6,860 | 6.8 K to 6.9 K (+1.42 %) |